Oxford BioMedica Share Price (OXB)

5.05 +0.01 (+0.20%) delayed: 5:59AM BST
Bid price 4.75 Open price 0.00
Ask price 5.35 Prev close 5.04
High price 0.00 Spread 11.21%
Low price 0.00 Volume 0

Register now for FREE live Oxford BioMedica share prices, Oxford BioMedica stock quotes, charts, trades market news and much much more. Why not upgrade to a premium service and get Oxford BioMedica Level 2 Data, indepth research tools and investor commentary for Oxford BioMedica (OXB) and other London Stock Exchange equities.

Oxford BioMedica Share Price Chart

Advanced Charts >>

Register now for FREE Oxford BioMedica share price charts

Oxford BioMedica Share Price Information

Name Oxford BioMedica Epic OXB
Sector Pharmaceuticals & Biotechnology ISIN GB0006648157
Activites Oxford BioMedica plc is a biopharmaceutical company developing innovative gene-based medicines and therapeutic vaccines that aim to improve the lives of patients with high unmet medical needs. The Company's technology platform includes a highly efficient LentiVector gene delivery system, which has specific advantages for targeting diseases of the central nervous system and the eye; and a unique tumour antigen (5T4), which is an ideal target for anti-cancer therapy. Through in-house and collaborative research, Oxford BioMedica has a broad pipeline with current partners and licensees including Sanofi, Pfizer, Novartis, GlaxoSmithKline, MolMed, Sigma-Aldrich, Biogen Idec, Emergent BioSolutions, ImaginAb and Immune Design Corp. Index n/a

Oxford BioMedica Key Numbers

Latest Share Price (p) 5.05 Net Gearing (%) 50.92
Market Capitalisation (£m) 151.33 Gross Gearing (%) 77.85
Shares in issue (m) 3,088.31 Debt Ratio 73.51
P/E Ratio -8.17 Debt-to-Equity Ratio 0.79
Total dividends per share (p) 0.00 Assets / Equity Ratio 4.51
Dividend Yield (%) 0.00 Price to book value 11.99
Dividend cover (x) 0.00 ROCE (%) -42.65
Earning per share (p) -0.60 EPS Growth (%) -17.65
52 week high / low 6.00 / 2.57 DPS Growth (%) n/a

Oxford BioMedica Director Deals

Dec.Date Type Director Pos No. of Shares
24/05/2017 BUY Dr Lorenzo Tallarigo CH 53,260
24/04/2017 BUY Dr Lorenzo Tallarigo CH 54,090
24/02/2017 BUY Dr Lorenzo Tallarigo CH 67,165
24/01/2017 BUY Martin Diggle NED 200,000
24/01/2017 BUY Martin Diggle NED 600,000

More Oxford BioMedica Director Deals >>

Oxford BioMedica Company News

16:25 24/05/2017

Director Deals - Oxford BioMedica PLC (OXB)

Dr Lorenzo Tallarigo, Chairman, bought 53,260 shares in the company on the 24th May 2017 at a price of 5.10p. The Director now holds 1,940,940 shares. Story provided by StockMarketWire.com Director deals data provided by www.directorsholdings.com

13:55 24/05/2017

Director/PDMR Shareholding

RNS Number : 1337G Oxford Biomedica PLC 24 May 2017               Director Dealings / Market Share Purchase   Oxford, UK - 24 May 2017:   Oxford BioMedica plc ("Oxford BioMedica" or "the Group") (LSE: OXB), a leading gene and cell therapy...

14:10 23/05/2017

All resolutions passed at AGM of Oxford BioMedica

Oxford BioMedica has announced that all resolutions proposed were duly passed at its Annual General Meeting, held today in London. At 2:10pm: (LON:OXB) Oxford BioMedica PLC share price was +0.11p at 4.99p Story provided by StockMarketWire.com

More Oxford BioMedica Company News >>

Register now for FREE Oxford BioMedica company news

Oxford BioMedica Share Price Discussions

more than 1 year ago

CANCER drug co. Oxford Biomedica charts (OXB)

OK so you thought the title of the other thread was out of date BUT unfortunately there is no way to edit thread titles. So here is a new title This one has got the charts at the top again & has a link to the old one. http://www.moneyam.com/InvestorsRoom/posts.php?tid=5021

more than 1 year ago


Very strong rumours of a further predator around. CAT,WYEYH,JOHNSON&JOHNSON,MERCK to name a few.............could be an exciting week ...!

more than 1 year ago


Very strong rumours of a further predator.........CAT,JOHNSON&JOHNSON,WYETH,MERCK to name a few. Could be an interesting week..!

Register now for FREE Oxford BioMedica share price discussions